Navigation Links
Nuvelo Initiates Phase 1B Clinical Trial of Anticoagulant NU172
Date:6/4/2008

- Phase 2 trial expected to begin in late 2008 or early 2009 -

SAN CARLOS, Calif., June 4 /PRNewswire-FirstCall/ -- Nuvelo, Inc. (Nasdaq: NUVO) today announced that it has enrolled the first patient in a single-center, Phase 1b trial to determine the safety, tolerability and pharmacokinetics of bolus plus infusion dosing of NU172, a direct thrombin-inhibiting aptamer, in approximately 30 healthy male volunteers.

"We were very encouraged by the findings of the initial Phase 1 proof-of-concept trial showing NU172's potential to address the need for rapid onset and offset of anticoagulation in the setting of medical or surgical procedures such as coronary artery bypass graft (CABG) surgery and percutaneous coronary intervention," said Dr. Ted W. Love, chairman and chief executive officer of Nuvelo. "This Phase 1b trial will study bolus dosing followed by escalating infusion doses of NU172 for up to four hours, mimicking the drug's potential administration in CABG surgery. We will complete this trial in the third quarter of this year and anticipate moving forward with a Phase 2 study in the fourth quarter of 2008 or the first quarter of 2009."

Data from the single-center, Phase 1 trial showed that bolus doses of NU172 produced dose-dependent increases in anticoagulation, measured by activated clotting time (ACT). Upon discontinuation of NU172 the ACT showed a rapid return toward baseline with a plasma half-life of approximately 10 minutes. No serious adverse events occurred in the trial.

About Aptamers and NU172

Aptamers are chemically synthesized single-stranded nucleic acids that form well-defined three-dimensional shapes, allowing them to bind target molecules in a manner that is conceptually similar t
'/>"/>

SOURCE Nuvelo, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Nuvelo Announces Positive Proof-of-Concept Data With Anticogulant NU172
2. Nuvelo Announces Preclinical Data for NU206 Demonstrating Potent Therapeutic Activity in Oral Mucositis Models
3. Nuvelo Announces Phase 2 SONOMA-3 Trial Did Not Meet Target Product Profile and Discontinues Alfimeprase Development
4. Nuvelo Initiates Phase 1 Clinical Trial of Thrombin Inhibitor, NU172
5. Nuvelo Begins Phase 2 Trial and Receives Fast Track Status for Alfimeprase in Patients With Acute Ischemic Stroke
6. Nuvelo Announces Alfimeprase SONOMA-2 Catheter Occlusion Data Presentation Webcast and Conference Call
7. Nuvelo Re-Initiates SONOMA-3 Trial of Alfimeprase in Patients With Catheter Occlusion
8. Anadys Pharmaceuticals Initiates Phase I Clinical Trial of ANA598
9. Wyeth Initiates INTORACT -- A New Clinical Trial to Examine TORISEL Plus Avastin for First-Line Treatment of Advanced Kidney Cancer
10. Human Genome Sciences Initiates First Clinical Trial of Lead IAP Inhibitor HGS1029 in Advanced Solid Tumors
11. Sunesis Pharmaceuticals Initiates Phase 2 Clinical Trial of Voreloxin (SNS-595) in Acute Myeloid Leukemia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... 6, 2015 Mauna Kea ... multidisciplinary confocal laser endomicroscopy platform, announced today it ... Ministry of Health, Labor and Welfare (MHLW) ... the AQ-Flex 19 miniprobe.   Used ... miniprobe is comprised of a fiber-optic microscope that ...
(Date:7/6/2015)... 6, 2015   BioClinica®, Inc ., a ... announced that it has acquired a leading global ... Inc. (Medici).  The acquisition includes affiliates MediciGlobal ... also provides a lost-to-follow-up patient locate service ( ... with Medici, BioClinica will offer pharmaceutical ...
(Date:7/6/2015)... DUBLIN, Ohio , July 6, 2015 ... of The Harvard Drug Group (THDG). A distributor of generic ... and alternate care customers, THDG was owned by Court ... all-cash transaction using existing cash and new debt.  ... , The Harvard Drug Group had revenues of approximately ...
Breaking Medicine Technology:Mauna Kea Technologies Receives Regulatory Approval for the AQ-Flex 19 Miniprobe in Japan 2Mauna Kea Technologies Receives Regulatory Approval for the AQ-Flex 19 Miniprobe in Japan 3BioClinica Acquires MediciGroup 2BioClinica Acquires MediciGroup 3Cardinal Health Completes Acquisition Of The Harvard Drug Group For $1.115 Billion 2Cardinal Health Completes Acquisition Of The Harvard Drug Group For $1.115 Billion 3
... May 10th, 2007 - Antisense,Pharma, a German biopharmaceutical ... announced, that data from the,Phase IIb-study with AP ... 43rd Annual Meeting of the American Society of,Clinical ... Illinois,U.S.A, from June 1st - 5th. , In ...
... NICE Appraisal Committee concludes that alteplase is clinically,and ... 2007 – A new clinical appraisal,published by the ... the UK has recommended the use of alteplase,for ... based on,its clinical and cost effectiveness compared with ...
Cached Medicine Technology:2007 ASCO Annual Meeting: Clinical Results on Phase IIb-study with,AP 12009 in Anaplastic Astrocytoma selected for Poster Discussion 22007 ASCO Annual Meeting: Clinical Results on Phase IIb-study with,AP 12009 in Anaplastic Astrocytoma selected for Poster Discussion 3Actilyse (alteplase) Recommended by National Institute for Health,and Clinical Excellence for Treatment of Acute Ischaemic Stroke 2Actilyse (alteplase) Recommended by National Institute for Health,and Clinical Excellence for Treatment of Acute Ischaemic Stroke 3Actilyse (alteplase) Recommended by National Institute for Health,and Clinical Excellence for Treatment of Acute Ischaemic Stroke 4Actilyse (alteplase) Recommended by National Institute for Health,and Clinical Excellence for Treatment of Acute Ischaemic Stroke 5
(Date:7/6/2015)... ... 2015 , ... Cancer Hope Network (CHN) has relaunched their ... to chat with the CHN patient services team and connect with a Support ... often the most traumatic experience of a person’s life,” said CHN Executive Director, ...
(Date:7/6/2015)... (PRWEB) , ... July 06, 2015 , ... MD Now, ... Monday, July 6. The newly constructed urgent care center will serve residents and visitors ... In addition to being MD Now’s 22nd South Florida location, the new facility will ...
(Date:7/6/2015)... ... July 06, 2015 , ... World renowned Los Angeles facial plastic surgeon ... appearance through comprehensive treatment solutions. Individuals that want to make multiple changes to their ... plan that resolves each of their needs. , "Anytime I see an opportunity ...
(Date:7/6/2015)... ... July 06, 2015 , ... Diabetes affects many of ... than 29 million Americans have diabetes, the majority of which are Type 2. However, ... or more than one in three, have prediabetes (abnormally high blood sugar levels). Without ...
(Date:7/5/2015)... ... July 06, 2015 , ... City Sports, the Boston-based ... will co-produce two training clinics for first-time triathletes this summer with ethos, the owner ... place on Thursday, July 9, at 6:00 p.m. at the North End Greenway. The ...
Breaking Medicine News(10 mins):Health News:Cancer Hope Network Launches Upgraded Website to Support Cancer Patients, Caregivers 2Health News:MD Now Urgent Care Opens its Fourth Miami-Dade County Facility in Cutler Bay 2Health News:MD Now Urgent Care Opens its Fourth Miami-Dade County Facility in Cutler Bay 3Health News:Los Angeles Plastic Surgeon, Dr. Paul Nassif, is Now Offering Comprehensive Facial Plastic Surgery Procedures 2Health News:115 Million in the U.S. could beat diabetes with the help of a new app 2Health News:Sporting Goods Retailer City Sports Renews Partnership with Boston Triathlon 2Health News:Sporting Goods Retailer City Sports Renews Partnership with Boston Triathlon 3
... VILLAGE, Calif., Jan. 6 Specialists On Call, ... the states in which it provides service, including ... provider of emergency neurology on-call services to hospitals, ... consultations to date.(Logo: http://www.newscom.com/cgi-bin/prnh/20081022/LAW515LOGO )Dr. Joe ...
... OF PRUSSIA, Pa., Jan. 6 Prism Pharmaceuticals, Inc.,announced ... Executive,Officer, will present at the 27th Annual J.P. Morgan ... (Pacific Time) or 10:30 a.m. (Eastern,Time). The conference ... in San,Francisco, California. , Dr. ...
... Inc. (NYSE: WLP ), the,nation,s largest ... today the expansion of its innovative disease management ... members in its affiliated health,plans suffering from Bipolar ... each year. The Bipolar Condition Care Program will ...
... Specialists On Call, Inc. (SOC) announced today that ... provides service, including California. SOC is the ... to hospitals, having already managed more than 5,500 ... )Dr. Joe Peterson, CEO, described the company,s ongoing ...
... Therapeutics, Inc.,(Nasdaq: OREX ), a biopharmaceutical company ... Company will be speaking at the 27th Annual,J.P. Morgan ... Date: Monday, January 12, 2009, ... a.m. Pacific, Location: Westin St. Francis, ...
... in "CVS/pharmacy dollars" throughout the last quarter of ... easy for consumers to save money WOONSOCKET, R.I., ... today announced that ExtraCare cardholders received more than ... 2008, simply by using their ExtraCare card when ...
Cached Medicine News:Health News:Specialists On Call Expands Access to Emergency Neurology On-Call Services in North Carolina 2Health News:WellPoint Announces Innovative Program to Help Improve the Care of Members Suffering With Bipolar Disorder 2Health News:WellPoint Announces Innovative Program to Help Improve the Care of Members Suffering With Bipolar Disorder 3Health News:Specialists On Call Expands Access to Emergency Neurology On-Call Services in California 2Health News:CVS/pharmacy Offers Shoppers More Than $69 Million in 'Extra Bucks' 2Health News:CVS/pharmacy Offers Shoppers More Than $69 Million in 'Extra Bucks' 3
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: